Concepedia
Statistics
Publications
109
Citations
9.1K
H-Index
56
Active since
1974
Affiliations
Karolinska Institutet(Current)
Karolinska University Hospital
Uppsala University Hospital
Uppsala University
Linköping University
Marja‐Liisa Dahl is an author at Karolinska Institutet specializing in pharmacology, medicine, and pharmacogenetics.
Publications per year
1974–2021
Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine.
Ida Johansson, E Lundqvist, Leif Bertilsson et al. · Proceedings of the National Academy of Sciences · 1993 · 647 citations
Medicine, Genetics, Molecular Genetics +17
CYP2D6 and CYP2C19 genotype‐based dose recommendations for antidepressants: a first step towards subpopulation‐specific dosages
Julia Kirchheiner, Kim Brøsen, Marja‐Liisa Dahl et al. · Acta Psychiatrica Scandinavica · 2001 · 423 citations
Medicine, Pharmacokinetics, Pharmacology +17
Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
Klas R. Linderholm, Elisabeth Skogh, Sara K. Olsson et al. · Schizophrenia Bulletin · 2010 · 315 citations · Full text
Life Sciences, Neuroscience, Pharmacology +13
Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis.
Marja‐Liisa Dahl, Inger Johansson, Leif Bertilsson et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 314 citations
10-hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes*
Per Dalén, Marja‐Liisa Dahl, Maria Luisa Bernal Ruiz et al. · Clinical Pharmacology & Therapeutics · 1998 · 286 citations
1–5 of 109